Breast Cancer in Europe: Epidemiology, Risk Factors, Policies and Strategies. A Literature Review

Abstract

INTRODUCTION: Breast cancer is the most commonly diagnosed cancer in European women, accounting for 28.8% of the total number of cancer diagnosis in Europe. Over the past few decades, several factors have led to remarkable improvements in overall breast cancer outcomes in Europe, such as early detection, screening, and progresses in treatment. However, breast cancer remains the most common cancer in females in Europe, yet more there is an increase in the incidence and mortality rates in some European countries. This research summarizes the current status of breast cancer in Europe, including epidemiology, risk factors, policies, and strategies. The results can help to better identify this health problem, which could help in developing better breast cancer control or prevention strategies and policies.
 
 METHODS: A literature review was conducted using five electronic databases (PubMed, Google Scholar, ProQuest, Eurostat, BioMed) and the European Commission reports for studies that reported on epidemiology and risk factors of breast cancer, or policies and strategies that target it in Europe. In addition, the Social Ecological Model (SEM) was used in categorizing the breast cancer risk factors into different levels.
 
 RESULTS: Europe and North America have the highest rate of breast cancer globally. Incidence and prevalence of breast cancer vary across Europe, and so does its mortality rates. Breast cancer was found to be associated with a number of risk factors, including but not limited to aging, use of hormone therapy, older age at the first birth, and smoking which are common in Europe. Cancer in general, and breast cancer have attracted specific attention, and the European Union has focused many of the resources and expertise on the topic.
 
 CONCLUSION & RECOMMENDATIONS: Breast cancer remains a major public health issue in Europe, despite the efforts and actions being taken. Therefore, current efforts against breast cancer in Europe need to be revisited and improved.

Breast Cancer in Middle Euphrates Region of Iraq: Risk Factors, Presenting Symptoms and Time to Medical Help-Seeking

“…Unhealthy life style was the main risk factor in our patients same results among Indian and Jordanian women [31][32]. But in Europe the use of hormone therapy, older age at the first birth and smoking were common risk factors [33]. On other hand about 12.8% of our patients had family history of breast cancer.…”

Economic Evaluation for Palbociclib Plus Fulvestrant vs Ribociclib Plus Fulvestrant and Abemaciclib Plus Fulvestrant in Endocrine-Resistant Advanced or Metastatic Breast Cancer in Italy

“…1 Breast cancer is a complex disease, it has four main distinct molecular subtypes: luminal A and B, human epidermal growth factor receptor 2 (HER2)-enriched, basal-like. 3 Luminal represents the most widespread type of breast cancer and is typified by the expression of the estrogen receptor (ER) and/or the progesterone receptor (PR), which can be effectively targeted with endocrine treatment. Sequential hormone therapies are the standard treatment regimens for hormone receptor positive (HR+)/HER2-negative (HER2-) advance and metastatic breast cancer (MBC) patients.…”

Poly(ADP-ribose) polymerase inhibitors in the treatment landscape of triple-negative breast cancer (TNBC)

“…1 Previously, the high incidence of BC was in America and Europe rather than in Asia and Africa. 2 However, recently, there is an increasing incidence of breast cancer in Asia. 3 It has the highest incidence compared to other continents, and the cases are more predominant in China, India, and Japan.…”